SEC Form 4 · accession 0001493152-26-028117
OKYO Pharma Ltd · OKYO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gabriele M Cerrone
Director · 10% Owner
Period of report
Jun 8, 2026
Accepted (ET)
Jun 10, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001849296
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Jun 8, 2026 | A | 300,000 | $1.72 | A | 10,826,416 | I | Via Panetta Partners Limited |
Table II — derivative securities
No Table II lines on this filing.